Castleview Partners’s PMV Adaptive Risk Parity ETF ARP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.89M Sell
114,125
-3,189
-3% -$107K 1.7% 12
2026
Q2
$3.81M Sell
117,314
-847
-0.7% -$27.7K 1.67% 13
2026
Q1
$3.71M Buy
118,161
+1,020
+0.9% +$32.7K 1.9% 9
2025
Q4
$3.54M Sell
117,141
-672
-0.6% -$21.2K 1.75% 12
2025
Q3
$3.62M Buy
117,813
+38,659
+49% +$1.13M 1.97% 9
2025
Q2
$2.25M Buy
79,154
+2,250
+3% +$62.5K 1.45% 12
2025
Q1
$2.13M Buy
+76,904
New +$2.12M 1.44% 11

Other funds holding ARP

Castleview Partners's ARP Position: Q3 2026 in Review

Castleview Partners reduced its PMV Adaptive Risk Parity ETF (ARP) stake by 2.7% in Q3 2026, selling an estimated $107K and leaving 114,125 shares worth $3.89M. The position accounts for 1.7% of the portfolio, ranked #12.

Castleview Partners first reported a position in ARP in Q1 2025 and has held it in 7 quarters since. 3 funds tracked by Wall St. Rank hold ARP as of Q3 2026.

  • Castleview Partners held 114,125 shares of PMV Adaptive Risk Parity ETF worth $3.89M as of Q3 2026.
  • Castleview Partners sold 3,189 PMV Adaptive Risk Parity ETF shares in Q3 2026, an estimated $107K.
  • PMV Adaptive Risk Parity ETF made up 1.7% of Castleview Partners's portfolio in Q3 2026, its #12 holding.
  • Castleview Partners first reported a position in PMV Adaptive Risk Parity ETF in Q1 2025 and has held it in 7 quarters since.
  • 3 funds tracked by Wall St. Rank held PMV Adaptive Risk Parity ETF as of Q3 2026.

Based on Castleview Partners's 13F filing for Q3 2026, filed 9 Oct 2026.